msb promises what mla is delivering, page-4

CT/Jessie,

I wouldn't be expecting big sales growth/profit for another 2 quarters.

From the last quaterly looks like existing business is around cash flow break even and they have now spent $500k on UK labs.

Initial UK Tutavet (medivet) procedures will probably be offered free to build coverage and vet awareness.

We haven't heard much from ALT on hospital testing results so sales here are also unlikely during current quarter.

Still a good story but DYOR.